Literature DB >> 15747308

[Optimization of a HFR sorbent cartridge for high molecular weight uremic toxins].

M L Wratten1, L Sereni, M Lupotti, P M Ghezzi, M Atti, M Formica.   

Abstract

HFR is a hemodiafiltration method with regeneration of the ultrafiltrate. It consists of a double chamber filter that separates convection from diffusion. The ultrafiltrate exits from the convective filter, passes through a sorbent cartridge where uremic toxins bind to the sorbent. The "purified" ultrafiltrate is then returned to the patient. This study undertook a series of in vitro and ex vivo experiments to optimize the conditions for maximal adsorption and treatment efficacy. An emphasis was placed on a resin only cartridge as previous studies suggested that some patients may be sensitive to the activated carbon, particularly if they are taking ACE inhibitors.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15747308

Source DB:  PubMed          Journal:  G Ital Nefrol        ISSN: 0393-5590


  4 in total

1.  A novel option for reducing free light chains in myeloma kidney: supra-hemodiafiltration with endogenous reinfusion (HFR).

Authors:  Sonia Pasquali; Francesco Iannuzzella; Mattia Corradini; Silvia Mattei; Achiropita Bovino; Alfredo Stefani; Giuseppe Palladino; Marialuisa Caiazzo
Journal:  J Nephrol       Date:  2014-08-23       Impact factor: 3.902

2.  Efficacy of Supra-HFR in Removing FGF23 and Cytokines: A Single Session Analysis.

Authors:  Gabriele Donati; Andrea Angeletti; Maria Cappuccilli; Chiara Donadei; Chiara Guglielmo; Anna Scrivo; Lorenzo Gasperoni; Maddalena Zambelli; Maria Mattiotti; Gaetano La Manna
Journal:  In Vivo       Date:  2022 Jul-Aug       Impact factor: 2.406

3.  Evidence that p-cresol and IL-6 are adsorbed by the HFR cartridge: towards a new strategy to decrease systemic inflammation in dialyzed patients?

Authors:  Eleonora Riccio; Mauro Cataldi; Maristella Minco; Gennaro Argentino; Roberta Russo; Stefania Brancaccio; Andrea Memoli; Lucia Grumetto; Loredana Postiglione; Bruna Guida; Bruno Memoli
Journal:  PLoS One       Date:  2014-04-22       Impact factor: 3.240

4.  Vitamins (A, C and E) and oxidative status of hemodialysis patients treated with HFR and HFR-Supra.

Authors:  Simonetta Palleschi; Paolo M Ghezzi; Giuseppe Palladino; Barbara Rossi; Marino Ganadu; Domenica Casu; Maria Cossu; Giovanni Mattana; Antonio Maria Pinna; Bruno Contu; Tonina Ghisu; Alessandro Monni; Luana Gazzanelli; Maria Cristina Mereu; Franco Logias; Mario Passaghe; Alessandro Amore; Piergiorgio Bolasco
Journal:  BMC Nephrol       Date:  2016-08-26       Impact factor: 2.388

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.